Santiago Arroyo - 06 Feb 2024 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Reporting relationship: CHIEF DEVELOPMENT OFFICER
Issuer ticker: BCYC
Reported as of: 06 Feb 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Feb 2024, 16:42:57 UTC
Prior SEC filing: 04 Jan 2024
Next SEC filing: 06 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Jason Minio, Attorney-in-Fact

Key filing fact

Santiago Arroyo filed Form 4 for BICYCLE THERAPEUTICS plc (BCYC) on 08 Feb 2024.

Key facts

This page summarizes Santiago Arroyo's Form 4 filing for BICYCLE THERAPEUTICS plc (BCYC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Feb 2024, 16:42.

Change

Previous filing in this sequence was filed on 04 Jan 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCYC transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +21,660
Change %: +125%
Price: $0.000000
Shares after: 39,000
Date: 06 Feb 2024
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCYC transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +41,570
Change %
Price: $0.000000
Shares after: 41,570
Date: 06 Feb 2024
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 41,570
Exercise price: $17.00
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

Footnote F2

Each RSU represents a contingent right to receive one ordinary share.

Footnote F3

This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares in 36 equal monthly installments thereafter.